WHR (WHR)

Market Cap
P/E Ratio
Beta
Dividend Yield
Piotroski 5/9Beneish M -2.54 Clean

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of WHR presents a mixed fundamental picture, characterized by an ROIC-WACC spread that is insufficient to drive robust value creation. The DuPont decomposition reveals that the 11.7% return on equity relies heavily on financial leverage rather than operational excellence; specifically, the high equity multiplier of 5.89x compensates for thin net margins of just 2.1%, while asset turnover remains modest at 0.97x. This structural reliance on debt magnifies downside risk if earnings compress further, a concern underscored by negative revenue growth of -6.5% year-over-year and a declining gross margin trajectory relative to the shrinking top line. While the Piotroski F-Score of 5/9 suggests moderate financial health with no severe distress signals, the Beneish M-Score of -2.54 indicates low probability of earnings manipulation, lending credibility to the reported but weak profitability metrics despite the lack of sector context for comparison.

Valuation positioning remains opaque without historical or peer benchmarks, yet the combination of negative revenue growth and minimal net margins creates a challenging environment for multiple expansion. The market appears to be pricing in limited organic growth potential given the -6.5% contraction, which may suppress forward P/E multiples even if the low manipulation risk supports earnings quality. A discounted cash flow analysis would likely yield a constrained fair value due to the inability of current operations to generate significant free cash flows at scale without substantial margin improvement or asset base optimization. Consequently, any implied growth rate derived from these fundamentals appears inconsistent with the observed revenue deterioration, suggesting the stock may be trading on residual leverage benefits rather than sustainable earnings power.

Recent insider activity shows a net buying flow of $198,829 over the past 90 days, providing a modest counterweight to the deteriorating top-line trends and offering limited evidence of confidence from management regarding future prospects. However, this capital inflow is relatively small in absolute terms compared to typical institutional positioning for public equities and does not necessarily offset the fundamental headwinds indicated by shrinking revenues and low operating leverage. Without additional data on risk factor deltas or Fama-French alpha performance, the risk-reward profile appears skewed toward downside protection via high debt usage rather than upside participation from operational improvement.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
-2.54
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

15.4%
Gross Margin
2.1%
Net Margin
7.1%
ROIC
-6.5%
Revenue Growth (YoY)
+198.4%
Earnings Growth (YoY)
81.0M
Free Cash Flow
370%
FCF Payout Ratio

⚠️ Dividend consumes >80% of FCF — sustainability risk.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

2.1%
Net Profit Margin
NI ÷ Revenue
×
0.97x
Asset Turnover
Revenue ÷ Assets
×
5.89x
Equity Multiplier
Assets ÷ Equity
=
11.7%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

4.89x
Debt / Equity
0.76x
Current Ratio
2.5x
Interest Coverage
4.1x
Net Debt / EBITDA
1.2B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
+$198,829
Net Buying
1
Buy Transactions
0
Sale Transactions
2026-03-03CREED GREGBuy$198,829
2026-03-03BITZER MARC RSold 1/8 qtrsOther3,110 shares
2026-02-27BEAUFILS LUDOVICOther795 shares
2026-02-27WARNER ROXANNEOther712 shares
2026-02-27DE JONG KYLE PETEROther902 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.70
Act: $1.70
+0.3%
Q3
✗ Miss
Est: $1.74
Act: $1.34
-23.0%
Q2
✓ Beat
Est: $1.39
Act: $2.09
+50.2%
Q1
✗ Miss
Est: $1.52
Act: $1.10
-27.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

Forward P/E
PEG Ratio
Price/Book
Avg Volume
52W High
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$208M
Tracked Passive Exposure
8
ETFs Holding WHR
0.09%
Avg Weight in ETFs
$235B
Total ETF AUM

When investors buy or sell ETFs like DVY or MDYV, the fund manager is mechanically forced to buy or sell WHR shares regardless of WHR's individual fundamentals. We estimate $208M of passive capital is structurally linked to WHR through 8 tracked ETFs. Passive flows have a limited but growing influence on WHR's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in WHR to visualize passive redemption contagion across ETFs and collateral stocks.

WHR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
WHREpicenterVYMETFVBRETFMDYETFAMZNLow RiskTSLALow RiskHDLow RiskSTXLow RiskMCDLow Risk
WHR Price Drop (%)0

If WHR (WHR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Amazon.com Inc. (AMZN) as the most exposed collateral stock, sharing 1 ETFs with WHR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 9 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

WHR Ownership Dynamics

Ticker
WHR

Float lock-up computed from 9 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

WHR Capital Efficiency

How efficiently does WHR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$81M
EBITDA
$1.2B
FCF Conversion
7%
Reinvestment Rate
93%
7% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

WHR converts 7% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 93% reinvestment rate signals aggressive capacity expansion.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-13712$41.29$29,398.48
2026-05-114,919$44.96$221,158.24
2026-05-0822,194$48.21$1.1M
2026-05-055,470$53.07$290,292.9
2026-05-04247,761$56.57$14.0M
2026-05-0171,602$56.06$4.0M
2026-04-301,130$54.64$61,743.2
2026-04-29140,028$55.20$7.7M
2026-04-2869,039$55.77$3.9M
2026-04-2783,523$53.80$4.5M
2026-04-24100,382$54.20$5.4M
2026-04-22303,966$56.91$17.3M
2026-04-21162,189$57.25$9.3M
2026-04-2028,282$56.83$1.6M
2026-04-1750,501$55.99$2.8M
2026-04-16144,934$55.75$8.1M
2026-04-157,953$55.27$439,562.31
2026-04-13559$56.51$31,589.09
2026-04-09154,253$56.16$8.7M
2026-04-08135$54.53$7,361.55
2026-04-0710,966$56.29$617,276.14
2026-04-0652,853$55.47$2.9M
2026-04-0252,111$54.28$2.8M
2026-03-311,731$50.87$88,055.97
2026-03-3014,275$51.92$741,158
2026-03-2776,095$53.61$4.1M
2026-03-26114,418$55.22$6.3M
2026-03-25218,124$53.84$11.7M
2026-03-2413,908$54.43$757,012.44
2026-03-2397,318$52.26$5.1M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare WHR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.